UPDATED Mar 16, 2024
Companies below a US$500M market cap with strong earnings growth forecasted for the next 3 years.
Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | Industry | ||
---|---|---|---|---|---|---|---|---|---|---|---|
NVG | zł2.39 | -5.5% | 83.8% | zł83.7m | zł3.71 | PE8.6x | E28.5% | n/a | Diversified Financials | ||
11B | zł515.00 | -6.5% | -22.6% | zł1.2b | zł688.50 | PE291.2x | E92.9% | n/a | Media | ||
ARH | zł26.00 | -6.1% | 39.4% | zł1.5b | zł35.10 | PE17.7x | E33.8% | 9.9% | Consumer Durables | ||
CRJ | zł580.00 | -1.4% | -29.7% | zł405.6m | zł760.00 | PE15.5x | E40.4% | 6.9% | Media | ||
SHO | zł30.30 | 7.1% | 15.2% | zł864.6m | zł36.17 | PE36.8x | E25.5% | 0.03% | Software | ||
PEN | zł7.75 | -4.3% | -39.9% | zł463.0m | zł10.21 | PS5x | E104.6% | n/a | Capital Goods | ||
VGO | zł524.00 | 2.3% | -4.0% | zł458.4m | zł591.50 | PE89.4x | E37.2% | 0% | Tech | ||
XTP | zł119.50 | -6.3% | 12.2% | zł271.2m | zł216.00 | PS17.9x | E131.6% | n/a | Tech | ||
PCF | zł23.70 | 0% | -32.3% | zł851.8m | zł42.83 | PE15.9x | E44.6% | 1.1% | Media | ||
CTX | zł65.60 | -18.2% | -54.3% | zł304.8m | zł115.00 | PS24.3x | E109.8% | n/a | Pharmaceuticals & Biotech | ||
PLW | zł262.50 | -4.0% | -36.4% | zł1.7b | zł381.00 | PE18.8x | E23.2% | 7.4% | Media | ||
OPN | zł54.00 | 2.7% | 40.3% | zł725.5m | zł57.40 | PE20.8x | E21.4% | 3.7% | Retail | ||
NWG | zł21.00 | 1.9% | 19.0% | zł945.0m | n/a | PE15x | E40.4% | 0% | Capital Goods | ||
KGN | zł62.00 | -5.5% | 135.7% | zł923.8m | zł137.00 | PE3.1x | E40.7% | 0% | Utilities | ||
IMS | zł4.38 | 9.0% | 73.8% | zł148.5m | zł4.60 | PE19.7x | E15.5% | 4.8% | Media | ||
VOX | zł94.40 | -1.5% | 119.5% | zł991.4m | zł79.00 | PE15.5x | E12.2% | 2.3% | Healthcare | ||
MUR | zł39.30 | -3.9% | n/a | zł1.6b | zł50.61 | PE7.6x | E13.3% | n/a | Real Estate Management and Development | ||
TEN | zł90.20 | -2.0% | -25.5% | zł655.3m | zł98.96 | PE68.2x | E53.8% | 8.0% | Media | ||
ECH | zł4.42 | -2.2% | 35.2% | zł1.8b | zł4.06 | PE51.3x | E45.7% | 10.0% | Real Estate Management and Development | ||
MLG | zł72.40 | -4.5% | -0.8% | zł1.7b | zł112.67 | PS5x | E25.3% | 0% | Real Estate Management and Development | ||
SLV | zł61.50 | 2.0% | -27.5% | zł1.1b | zł71.58 | PE46.3x | E32.7% | n/a | Pharmaceuticals & Biotech | ||
CBF | zł106.00 | 2.9% | 93.1% | zł1.5b | zł92.10 | PE39.5x | E27.9% | 0.9% | Telecom | ||
CLN | zł15.30 | 1.6% | 2.3% | zł781.2m | zł16.88 | PS3.6x | E59.5% | 0.6% | Pharmaceuticals & Biotech | ||
MBR | zł315.50 | 4.5% | 3.4% | zł1.1b | zł364.58 | PE12.9x | E14.1% | 4.2% | Commercial Services |